ABSTRACT: Asparagine (N)-linked glycosylation requires the ordered, stepwise synthesis of lipid-linked oligosaccharide (LLO) precursor Glc 3 Man 9 GlcNAc 2 -pyrophosphate-dolichol (Glc 3 Man 9 Gn 2 -PDol) on the endoplasmic reticulum. The fourth and fifth step of LLO synthesis are catalyzed by Alg2, an unusual mannosyltransferase (MTase) with two different MTase activities; Alg2 adds both an a1,3-and a1,6-mannose onto ManGlcNAc 2 -PDol to form the trimannosyl core Man 3 GlcNAc 2 -PDol. The biochemical properties of Alg2 are controversial and remain undefined. In this study, a liquid chromatography/mass spectrometry-based quantitative assay was established and used to analyze the MTase activities of purified yeast Alg2. Alg2-dependent Man 3 GlcNAc 2 -PDol production relied on net-neutral lipids with a propensity to form bilayers. We further showed addition of the a1,3-and a1,6-mannose can occur independently in either order but at differing rates. The conserved C-terminal EX 7 E motif, N-terminal cytosolic tail, and 3 G-rich loop motifs in Alg2 play crucial roles for these activities, both in vitro and in vivo. These findings provide insight into the unique bifunctionality of Alg2 during LLO synthesis and lead to a new model in which alternative, independent routes exist for Alg2 catalysis of the trimannosyl core oligosaccharide
In eukaryotes, N-glycosylation starts with assembly of a lipidlinked oligosaccharide (LLO) precursor, Glc 3 Man 9 GlcNAc 2 -pyrophosphate-dolichol (Glc 3 Man 9 Gn 2 -PDol), on the endoplasmic reticulum membrane (1) (2) (3) . Addition of the 14 LLO sugars is carried out sequentially by 12 different asparagine-linked glycosylation (Alg) glycosyltransferases (GTase) (4) (5) (6) . Extensive effort in the past three decades has led to the identification all the ALG genes required for LLO biosynthesis. The biochemistry of all the Alg GTases is also well characterized, with the exception of Alg2. Alg2 catalyzes addition of both the a-1,3-and a-1,6-linked mannose (Man) onto Man 1 Gn 2 -PDol to form the trimannosyl core Man 3 Gn 2 -PDol.
The molecular details of Alg2 have been a longstanding controversial issue, in part because it is an unusual GTase that catalyzes two different enzymatic reactions whose order has not been resolved. Earlier phenotypic analyses of yeast, fungal, and human alg2 mutants suggested Alg2 is required to elongate either Man 1 Gn 2 -PDol to Man 2 Gn 2 -PDol or Man 2 Gn 2 -PDol to Man 3 Gn 2 -PDol (5, (7) (8) (9) (10) . Both these reactions are catalyzed by Alg2 because recombinant Alg2 can elongate Man 1 Gn 2 -PDol substrate to produce Man 3 Gn 2 -PDol via a Man 2 Gn 2 -PDol intermediate (11) . Similarly, Alg2 immunoprecipitated from extracts of yeast microsomal membranes also displays both a1,3-and a1,6-mannosyltransferase (MTase) activities (12) . Because both in vitro and in vivo studies identified Man-(a1-3)-Man-Gn 2 -PDol as the only tetrasaccharide intermediate of the Alg2 reaction, the current accepted model for the order of Man addition by Alg2 is a1,3-mannosylation followed by a1,6-mannosylation to yield the branched core pentasaccharide product Man-(a1,3)[Man-(a1,6)]-Man 1 Gn 2 -PDol.
A problem with this model is it contradicts experiments conducted almost 40 yr ago that suggested the Man 2 Gn 2 -PDol tetrasaccharide intermediate is a mixture ABBREVIATIONS: 3HA, three N-terminal hemagglutinin in repeats; Alg, asparagine-linked glycosylation; CL, cardiolipin; DGDG, digalactosyldiglyceride; ESI-MS, electrospray ionization mass spectrometry; 5-FOA, 5-fluoroorotic acid; GDP, guanosine 59-diphosphate; Gn 2 , GlcNAc 2 ; GTase, glycosyltransferase; HA, hemagglutinin; IPTG, isopropyl-b-D-thiogalactopyranoside; LC-MS, liquid chromatography/mass spectrometry; LLO, lipid-linked oligosaccharide; Man, mannose; MTase, mannosyltransferase; PC, phosphatidylcholine; PDol, pyrophosphate-dolichol; PE, phosphatidylethanolamine; PPhy, pyrophosphate-phytanyl; PS, phosphatidylserine; Trx, thioredoxin; UPLC, ultraperformance liquid chromatography; WT, wild type of the Man-(a1-3)-Man-Gn 2 -PDol and Man-(a1-6)-ManGn 2 -PDol isomers. These earlier experiments showed that Man 2 Gn 2 -PDol isolated from yeast microsomes incubated with uridine diphosphate N-acetylglucosamine-GlcNAc and guanosine 59-diphosphate (GDP)- [ 14 C] Man contains about 85% Man-(a1-3)-Man-Gn 2 and 15% Man-(a1-6)-Man-Gn 2 (13) . In addition, two isomeric tetrasaccharide Man 2 Gn 2 -PDol intermediates, Man-(a1-3)-Man-Gn 2 -PDol and Man-(a1-6)-Man-Gn 2 -PDol, accumulate in yeast alg2 mutants (8) . These results imply that Alg2 can directly transfer the a1-6-linked Man to Man 1 Gn 2 -PDol. However, direct evidence for a1,6-mannosylation on Man 1 Gn 2 -PDol by purified Alg2 protein is lacking.
In addition to the order of the Alg2-mediated reactions, there are also conflicts in the literature regarding how Alg2 structure relates to its function. For instance, Alg2 contains a highly conserved EX 7 E motif, which is the signature sequence of CaZY families 3, 4, and 5 retaining GTases (14) . Several groups have investigated the biologic importance of the EX 7 E motif in enzyme activity of Alg2 but reported contradictory results (11, 12) .
Here we make use of a novel liquid chromatography/ mass spectrometry (LC-MS)-based Alg2 assay to help clarify the discrepancies that currently exist. We previously established an LC-MS-based quantitative assay for the Alg1 b1,4-MTase whose catalytic step precedes Alg2. In that assay, recombinant Alg1 generates Man-(b1,4)-Gn 2 -PPhy from a GlcNAc-(b1,4)-GlcNAc-pyrophosphate-phytanyl (PPhy):Gn 2 -PPhy acceptor substrate (15) . Here, we coupled this approach to develop a quantitative in vitro assay for Alg2, using the Alg1-generated Man 1 Gn 2 -PPhy product as the acceptor for purified Alg2. Analysis of Alg2 activity confirmed its dual a1,3-and 1,6-Alg2 MTase activities, which required the presence of lipids. This assay also permitted the successful separation and characterization of the tetrasaccharide intermediates of the Alg2 reaction, including both Man-(a1-6)-Man-Gn 2 and Man-(a1-3)-Man-Gn 2 LLOs. By combining mutational analyses of Alg2 in vitro and in vivo, we established an essential role of the EX 7 E putative catalytic motif, as well as 3 highly conserved G-rich loops, and the N-terminal cytosolic tail. These data lead to the proposal of a new model for LLO synthesis, in which the fourth and fifth steps can occur independently.
MATERIALS AND METHODS

Plasmid construction
To construct the Escherichia coli expression plasmid pET32-scAlg2, scALG2 was amplified from genomic Saccharomyces cerevisiae (sc) DNA and inserted into the pET32 BamHI and XhoI sites in frame with an N-terminal thioredoxin (Trx)-His 6 -tag (Thermo Fisher Scientific, Waltham, MA, USA). To construct the yeast expression plasmid pRS316-TEF-scALG2, the TEF1 promoter sequence (position 21 to 2500 upstream of TEF1) was cloned into the SacI and SpeI sites of pRS316, an integrative CEN6/URA3 vector to generate pRS316-TEF. The scALG2 open reading frame was then inserted downstream the TEF1 promoter as a SpeI and EcoRI fragment. To express scALG2 under its own promoter, 1 kB of ALG2 upstream sequence (position 21 to 21000 upstream of ALG2) was cloned in the SacI and SpeI sites of the CEN6/TRP1 integrative plasmid pRS314 to generate pRS314-ALG2pr. A SpeI/XhoI fragment containing the scALG2 open reading frame with 3 N-terminal hemagglutinin in repeats (3HA) was constructed by PCR and cloned into pRS314-ALG2pr. This generated pRS314-3HA-scALG2, in which scALG2 expression is driven by its own promoter. To generate a series of plasmids that expresses various alg2 mutant alleles as shown in figures 4-7, pRS314-3HA-ALG2 was subjected to mutagenesis by overlapping PCR (16) . All mutations and PCR-generated fragments were confirmed by DNA sequence analysis (BGI, Shenzhen, China). Sequences of primers used in this study are available upon request.
Expression and purification of recombinant Alg2 proteins
To purify recombinant yeast scAlg2 protein, pET32-scAlg2 was transformed into E. coli DE3 cells (Thermo Fisher Scientific), and positive clones were selected by ampicillin (100 mg/ ml) and chloramphenicol (34 mg/ml) resistance. Single colonies were cultured in Terrific-Broth (1.2% tryptone, 2.4% yeast extract, 0.5% glycerol, 17 mM KH 2 PO 4 and 72 mM K 2 HPO 4 ) at 37°C until the OD 600 value reached 1.0. Cultures were cooled to 16°C and induced with 0.1 mM isopropyl-b-D-thiogalactopyranoside (IPTG; Sangon Biotech, Shanghai, China). After ;12 h, cells were collected, resuspended in buffer A [25 mM Tris-HCl (pH 8.0); 150 mM NaCl], and disrupted by sonication on ice. After centrifugation to remove cellular debris (4000g, 20 min, 4°C), membranes in the lysate were pelleted by centrifugation (20,000g, 90 min, 4°C). Proteins in the membrane fraction were solubilized for 1 h in buffer A containing 1% Triton X-100. His-Alg2 was purified from the detergent-soluble membrane fraction by binding to a HisTrap HP affinity column (GE Healthcare Life Sciences, Little Chalfont, UK). Bound His-Alg2 was eluted with buffer A containing 0.5% Triton X-100 and 500 mM imidazole, dialyzed against buffer B [25 mM Tris-HCl (pH 8.0), 50 mM NaCl, 0.5% Triton X-100], and concentrated with Amicon Ultra 10K NMWL filter units (EMD Millipore, Billerica, MA, USA). Protein concentration was determined by the bicinchoninic acid assay (Sangon Biotech). Proteins from each step of purification were separated by 12% SDS-PAGE gel, followed by staining with Coomassie Brilliant Blue R-250.
Preparation of E. coli membrane and proteoliposomes
Bacterial membrane fractions used for in vitro Alg2 MTase assays were prepared from E. coli (DE3) harboring the empty plasmid pET32. Overnight cultures (10 ml) were disrupted by sonication in buffer A, followed by centrifugation (4000g, 20 min, 4°C) to remove cellular debris. Membranes were pelleted from the lysate by centrifugation at 100,000g for 60 min at 4°C. After homogenization in 50 ml of [50 mM Tris-acetate (pH 8.5); 30% glycerol], membranes were heated at 100°C for 3 min to inactivate endogenous proteins.
Proteoliposomes were prepared as described (17) . Briefly, commercially available lipids, including digalactosyldiglyceride (DGDG; Sigma-Aldrich, St. Louis, MO, USA), cardiolipin (CL; Sigma-Aldrich), phosphatidylserine (PS; Sigma-Aldrich), phosphatidylcholine (PC; Sinophara Chemical Reagent, Shanghai, China), and phosphatidylethanolamine (PE; Sinophara Chemical Reagent) were dissolved in chloroform-methanol (9:1, v/v). To obtain a thin layer of dry lipids, the solvent was removed under a nitrogen gas stream and high vacuum. Dry lipids were homogenized in 50 mM Tris-acetate (pH 8.5), and the resulting liposomes were mixed with purified recombinant Alg2 protein to a final concentration of 100 mg/ml lipid and 0.9 mg/ml protein.
Measurement of in vitro Alg2 MTase activity
The acceptor phytanyl oligosaccharide, Man-(b1,4)-Gn-(b1,4)-Gn-PP-phytanyl (Man 1 Gn 2 -PPhy), was synthesized from Gn-(b1,4)-Gn-PP-phytanyl (Gn 2 -PPhy) using yeast Alg1 as described (15) . The standard Alg2 assay reaction mixture contained 14 mM 2-(Nmorpholino)ethanesulfonic acid (pH 6.0), 4 mM potassium citrate, 10 mM MgCl 2 , 0.05% NP-40, 50 mM Man 1 Gn 2 -PPhy, 2 mM GDPMan (Sigma-Aldrich), 1 M sucrose, 10 ml of E. coli membrane, and 2 mM purified Alg2 in a total volume of 60 ml. To measure Alg2 in vitro activity as a function of lipid, instead of E. coli membranes, proteoliposomes were prepared as described above. Ten microliters of proteoliposomes was assayed using otherwise identical reaction conditions, incubated at 30°C for 10 h, and heated at 100°C for 3 min to inactivate Alg2 enzymatic activity.
Reaction products were analyzed as follows: 20 mM hydrogen chloride (0.2 ml) was added to the reaction to hydrolyze glycan-PP-phytanyl. After 1 h incubation at 100°C, the watersoluble glycan-containing fraction was desalted by solid-phase extraction using 1 ml Supelclean ENVI-Carb Slurry (SigmaAldrich) and lyophilized. Dried samples were dissolved in water before ultraperformance liquid chromatography (UPLC)-electrospray ionization-mass spectrometry (ESI-MS) analysis. Samples were analyzed on a TSQ Quantum Ultra (Thermo Fisher Scientific) coupled to a Dionex Ultimate 3000 UPLC system (Thermo Fisher Scientific). Glycans were applied to an Acquity UPLC BEH Amide column (1.7 mm, 2.1 3 100 mm; Waters, Beverly, MA, USA) and eluted with an acetonitrile gradient with a flow rate 0.2 ml/min. The gradient program was set as follows: 0 to 2 min, isocratic 80% acetonitrile; 2 to 15 min, 80 to 50% acetonitrile; 15 to 18 min, isocratic 50% acetonitrile. Eluent was monitored by measuring total ions at positive mode in the mass range of m/z 400 to 1000. The relative percentage of oligosaccharides was calculated according their peak intensity in LC-ESI-MS by Xcalibur 2.0 (Thermo Fisher Scientific).
Mannosidase digestions
Digestions of glycans (2.5 nM) with 3.2 U of a1,2-3-mannosidase (Xanthomonas manihotis; New England Biolabs, Ipswich, MA, USA), 4 U of a1,6-mannosidase (X. manihotis; New England Biolabs), and 0.1 mU of a1,2-mannosidase (Aspergillus saitoi; ProZyme, Hayward, CA, USA) were performed in 10 ml with buffers supplied by the manufacturer at 25°C for 16 h.
Yeast growth, strain construction, and plasmid shuffling S. cerevisiae W303a (MAT ahis3-11 leu2-3, 112 ura3-1 trp1-1 ade2-1 can1-100) was used as the parental strain in this study. Standard yeast genetic methods and media were used for the construction and growth of yeast strains (18) . YPAD contained 1% yeast extract, 2% peptone A, 50 mg/L adenine sulfate, and 2% glucose. Synthetic dextrose contained 6.7 g/L yeast nitrogen base, 2 g/L amino acid mix without appropriate selectable supplements, and 2% glucose. For solid media, agar was added to 2%.
LST1 (W303a plus TEFpr-scALG2::URA3) contains plasmidborne S. cerevisiae ALG2 whose expression is driven by the TEF1 promoter. LST1 was constructed by introducing the URA3-marked plasmid pRS316-TEF-scALG2 into W303a. Chromosomal ALG2 was then replaced with His3MX6 by PCR-mediated recombination to generate LST2 (LST1 plus alg2Δ::His3MX6) (19) . LST2 was transformed with a series of TRP1-marked plasmids (pRS314-3HA-scALG2), which express 3HA-tagged scALG2 wild type (WT) or alg2 mutant alleles under the control of the ALG2 promoter. Transformants (single colonies) were cultured in YPAD, followed by spotting on synthetic dextrose media lacking tryptophan and spotting on the same media containing 0.1% 5-fluoroorotic acid (5-FOA) to select for TRP1-marked plasmidborne ALG2 alleles and against the URA3-marked plasmid-borne ALG2.
Membrane protein isolation and Western blot analysis
Membrane proteins were extracted from yeast as described (20) . Briefly, exponentially growing yeast cells (5 OD 600 units) were collected and resuspended in 500 ml S-buffer (1 M sorbitol, 2 mM MgCl 2 , 0.14% b-mercaptoethanol, 50 mM Tris-HCl, pH 7.5) containing 10 U lyticase (Sigma-Aldrich). After incubation at 30°C for 30 min, spheroplasts were pelleted (9000g, 1 min, 4°C) and washed twice with ice-cold S-buffer. The spheroplast pellet was lysed in 400 ml ice-cold lysis buffer [0.2 M sorbitol, 1 mM EDTA, 50 mM Tris-HCl (pH 7.5), 1 mM PMSF] by 10 cycles of vortexing with glass beads (425-600 mm; Sigma-Aldrich) for 1 min and incubation on ice for 1 min. Cell debris was removed by low-speed centrifugation (3000g, 10 min, 4°C), and the supernatant was centrifuged at 100,000g for 30 min at 4°C. The resulting pellet was used as membrane fraction. After solubilization with lysis buffer containing 1% Triton X-100, protein concentration in these membrane fractions was determined by the bicinchoninic acid assay.
For Western blot analysis, 10 mg of protein was separated by 12% SDS-PAGE, followed by transfer onto PVDF (Bio-Rad, Hercules, CA, USA) membrane. The membrane was incubated with anti-hemagglutinin (HA) mouse antibody (TransGen Biotech, Beijing, China), washed, and incubated with anti-mouse IgG-horseradish peroxidase (TransGen Biotech). Immunoreactive bands were visualized by ECL (Bio-Rad).
RESULTS
New LC-MS-based quantitative assay confirms dual MTase activities of purified yeast Alg2
To develop an LC-MS-based assay to measure Alg2 enzyme activity, we first purified recombinant Alg2 protein from E. coli. Yeast ALG2 with an N-terminal Trx tag (11) was overexpressed in E. coli and purified from the membrane fraction as described in Materials and Methods. SDS-PAGE analysis of the purified protein revealed a single band of about 68 kDa, corresponding to Trx-scAlg2 (Fig. 1A) .
To produce the Alg2 LLO acceptor analog Man-(b1,4)-Gn 2 -PPhy, we used a chemoenzymatic approach (see Materials and Methods) (15) . This Man-(b1,4)-Gn 2 -PPhy acceptor was incubated with purified recombinant TrxscAlg2 for 10 h at 30°C. After chemical release from phytanyl, the glycan products were analyzed by UPLC-ESI-MS. To enhance sensitivity and avoid the ionization reduction of oligosaccharides by salt from UPLC eluent (21), we used only water and acetonitrile in the mobile phase, as this results in a stronger oligosaccharide signal in positive-mode ESI-MS. This procedure purportedly separates the released glycan into a-and b-anomeric forms of oligosaccharides ( Fig. 1B) (15) . Indeed, ESI-MS spectrum of these peaks gave a single molecular mass at m/z 609, corresponding to [Gn 2 -M + Na] + (Fig. 1C ). Using a standard reaction mixture containing purified scAlg2, LLO acceptor, and GDP-Man, scAlg2 activity was , respectively. These results demonstrated that recombinant scAlg2 attached 2 Man residues to Man 1 Gn 2 -PP.
To determine the structure of these oligosaccharides, the reaction product around 12.5 min was collected, digested with linkage-specific mannosidases, and again analyzed by ESI-MS (Fig. 1D ). This experiment demonstrated that the Alg2 reaction products were resistant to both a1,2-mannosidase and a1,6-mannosidase, but were sensitive to a1,6-mannosidase after treatment with a1,2-3-mannosidase (Fig. 1D) . Because the a1,6-mannosidase used in this experiment can only hydrolyze a terminal a1,6-Man linked to a nonbranched sugar, we inferred that recombinant scAlg2 transferred 2 Man residues to the b1,4-Man of the Man 1 Gn 2 -PPhy substrate with a1,6 and a1,3-linkages, yielding Man-(a1,3)[Man-(a1,6)]-Man 1 Gn 2 -PPhy. These two different Alg2-dependent activities are consistent with previous experiments that demonstrated its bifunctionality (11, 12) .
To quantitate each of the Alg2 MTase activities more carefully, the relative percentage of oligosaccharides remaining after completion of the reactions performed in Fig. 1B was determined. As shown in Table 1 , after a 10 h reaction, 95% of the Man 1 Gn 2 substrate was fully converted to the final Man 3 Gn 2 product when both 1 M sucrose and membranes were present (Fig. 1B, (Fig. 1B , cf. sucrose and membrane). These results also underscore that this assay is sufficiently sensitive to quantitatively distinguish differences in each of the 2 Alg2 MTase activities.
MTase activity of Trx-scAlg2 relies on net neutral-bilayer lipids
We wished to further explore the role of lipids on Alg2 activity. The enhancement of Alg2 enzyme activity was likely due to the presence of lipids rather than proteins because the membrane fraction added to the Alg2 reaction was denatured by heating at 100°C for 3 min (Fig. 1A) . To test this idea, and to investigate what type of lipid contributes to increased Alg2 activity, we prepared proteoliposomes consisting of purified TrxscAlg2 and different phospholipids, including PE, PS, CL, and PC. The choice of these lipids allowed a comparison of negatively charged (PS and CL) or neutral lipids (PE and PC) that also display different tendencies to form bilayers (PS and PC) or nonbilayer micelles (PE and CL) (22) . The results of this experiment demonstrated a clear hierarchy of lipid effects (Fig. 2) , with PC . .PE . ...PS = CL. Proteoliposomes consisting of purified Alg2 and PC converted Man 1 Gn 2 -PPhy to Man 3 Gn 2 -PPhy efficiently (81% product at reaction Reactions were performed using purified Trx-scAlg2, GDP-Man, and Man 1 Gn 2 -PPhy in 14 mM 2-(Nmorpholino)ethanesulfonic acid (pH 6.0), 4 mM potassium citrate, 10 mM MgCl 2 , 0.05% NP-40. After mixing, 1 M sucrose (sucrose), heat-inactivated E. coli membrane (membrane), or 1 M sucrose and membrane (sucrose and membrane) was added and reactions incubated at 30°C for 10 h. Oligosaccharides released from various LLOs in mixture were analyzed by LC-MS.
a Relative percentage of oligosaccharide was calculated by dividing area of each corresponding oligosaccharide peak to total area of all peaks. Chromatograms of oligosaccharides in each of these reactions are shown in Fig. 1B. product are indicated by arrows. C ) ESI-MS of glycans released from phytanyl oligosaccharides. Eluates shown in (A) were analyzed. Mass spectra of eluate from 8. time of 10 h), while PS-or CL-containing proteoliposomes were inactive ( Fig. 2A) . PE-mixed proteoliposomes converted 13% of substrate to Man 3 Gn 2 ( Fig. 2A) . One interpretation of these results is scAlg2 prefers zwitterionic-bilayer-prone lipid for its enzyme activity. To test this idea, another neutral bilayer lipid, DGDG, was tested. Alg2 activity in DGDG proteoliposomes was strongly enhanced (92% conversion of Man 1 Gn 2 -PPhy to Man 3 Gn 2 -PPhy) (Fig. 2B) 
-PPhy
To analyze the kinetics of the Alg2 reaction, we performed a time course, in which aliquots were removed at various times and analyzed by UPLC to measure short-lived reaction intermediates (Fig. 3A) . Interestingly, these intermediates were separated by UPLC into 3 distinct peaks around 11.0 min (Fig. 3A) . In contrast, only a single intermediate peak was identified by ESI-MS, which corresponded to [Gn 2 -M 2 + Na] + (Fig. 1B) . These results suggested the possibility that this ESI-MS Man 2 Gn 2 intermediate represents 2 isoforms, in which an a1,3-or a1,6-linked Man is attached at the nonreducing end of the Man 1 Gn 2 substrate. To test this, we determined the linkage of the added Man. UPLC fractions containing intermediates were collected and treated with a1,2-3-mannosidase and a1,6-mannosidase. As shown in Fig. 3B , although these peaks were partially sensitive to either of these mannosidases, simultaneous treatment with both mannosidases resulted in their complete conversion to Man 1 Gn 2 trisaccharide. In the tetrasaccharide mixture, the 10.64 and 10.93 min peaks that were the product of a1,2-3-mannosidase treatment originated from the Man-(a1,6)-Man 1 Gn 2 -PPhy (Fig. 3B, a1,2-3-mannosidase) , while the 10.90 min and 11.14 min eluted peaks originated from the Man-(a1,3)-Man 1 Gn 2 -PPhy because it is the product of a1,6-mannosidase (Fig. 3B, third row) . These results demonstrated that the intermediates identified by UPLC are a mixture of tetrasaccharides derived from Man-(a1,3)-Man 1 Gn 2 -PPhy and Man-(a1,6)-Man 1 Gn 2 -PPhy.
To further analyze the structure of the tetrasaccharide eluted from 10.6 to 11.0 min (Fig. 3B , second row), these two peaks were collected (Fig. 3C, left) and further treated with a1,6-mannosidase. This treatment resulted in complete conversion of this tetrasaccharide to Man 1 Gn 2 (Fig. 3C,  right) , demonstrating the presence of Man-(a1,6)-Man 1 Gn 2 in the intermediate mixture. Quantifying the area of the peaks revealed, after 2 h, 85% of the tetrasaccharide mixture was generated from Man-(a1,3)-Man 1 Gn 2 -PPhy and only 15% was from the Man-(a1,6)-Man 1 Gn 2 -PPhy. One interpretation of these data is that Trx-scAlg2 preferentially attached a1,3-linked Man to Man 1 Gn 2 -PPhy, followed by a1,6-linked Man to generate the final product Man-(a1,3) [Man-(a1,6)]-Man 1 Gn 2 -PPhy. These results are consistent with previous reports (11, 12) . Importantly, the existence of the Man-(a1,6)-Man 1 Gn 2 -PPhy intermediate unequivocally demonstrated Trx-scAlg2 can directly attach an a1,6-linked Man to Man 1 Gn 2 -PPhy, which is then followed by a1,3-mannosylation to yield Man 3 Gn 2 -PPhy. Figure 2 . Effect of lipids on Trx-scAlg2 activity. Trx-scAlg2 proteoliposomes, consisting of pure protein and lipids, were prepared as described in Materials and Methods and used to assay MTase activity in standard reaction mixture. After 10 h incubation at 30°C, glycan released from reaction products were subjected to LC-MS analysis. Trx-scAlg2 proteoliposomes were prepared using following lipids: PE, PS, CL, PC. B) TrxscAlg2 proteoliposomes were prepared with DGDG.
the effects of which were evaluated in vitro and in vivo.
Most retaining GTases have a conserved EX 7 E signature motif, whose role in catalysis as a nucleophile that stabilizes the donor substrate has been proposed (23, 24) . Alg2 has an EX 7 E motif in its C-terminal domain, but there are conflicting data about its importance. Kämpf et al. (12) reported the EX 7 E motif was not required for Alg2 GTase function, while O'Reilly et al. (11) reported the conserved EX 7 E motif is crucial. The importance of the Alg2 EX 7 E motif was tested by altering each of the conserved Glu residues (E335 or E343 in the scAlg2 protein) or the H336 and F337 in the intervening X7 region to alanines (Fig. 4A) . Each of these Trx-tagged mutant Alg2 proteins was expressed and purified from E. coli, and their activity measured using our MS-based in vitro assay (Fig. 1) . For each reaction, the relative percentage of oligosaccharide precursor, intermediate, and final product remaining after completion was determined ( Table 2 ). The result of this experiment demonstrated that all these residues were important to varying degrees. Trx-scAlg2
E335A
, mutated in the first E, had significantly decreased activity, producing no final product and only 32% of intermediate Man 2 Gn 2 ( Fig 4B and Table 2 ). Trx-scAlg2 E343A , mutated in the second E, had no detectable activity (Fig. 4B and Table 2 ). The intervening amino acids of the EX 7 E were also important, though less than either E335 or E343. Trx-scAlg2
H336A and Trx-scAlg2 F337A produced 8% and 26% Man 3 Gn 2 product, respectively ( Fig. 4B and Table 2 ). Together, these results are in agreement with O'Reilly et al. and provide strong evidence that the EX 7 E motif is important for Alg2 MTase activities in vitro. Each mutation was also analyzed in vivo by measuring complementation of the ALG2 deletion. Cells deleted for ALG2 are inviable, so we used a plasmid shuffling technique to measure complementation (25) . A yeast strain deleted for chromosomal ALG2 (LST2) but that is kept alive by ALG2 on a URA3-marked plasmid was constructed (see Materials and Methods). Each EX 7 
.). Conserved EX 7 E motif is marked in dark boxes. B) In vitro
MTase activities of Trx-scAlg2 EX 7 E mutants. Trx-scAlg2 proteins (mutant or WT) were expressed and purified from E. coli.
Reactions were performed at 30°C for 10 h under standard conditions as described in Materials and Methods. Released glycans were subjected to LC-MS. C ) Growth phenotypes of LSY2 strains harboring TRP1-marked plasmids, pRS314-3HA-scALG2 (WT), pRS314-3HA-scALG2 E335A (E335A), pRS314-3HA-scALG2 E343A (E343A), or pRS314-3HA (vector). Serial dilutions of strains expressing these plasmids were spotted on plates that contained uracil and 5-FOA but lacked tryptophan. As control, these strains were also spotted on plates lacking 5-FOA. Only cells expressing active Alg2 from TRP1-marked plasmid are able to grow on 5-FOA medium. Plates were incubated at 30°C for 48 h. D) Western blot analysis of scAlg2 proteins from S. cerevisiae. Membrane fractions of strains expressing each alg2 allele were prepared as described in Materials and Methods. Equal amounts of proteins were analyzed by Western blot using anti-HA antibody. mutant allele (Fig. 4A ) was introduced into this strain on a centromeric TRP1-marked plasmid. The rationale of this plasmid shuffling experiment is that URA3 cells are inviable in the presence of 5-FOA so there is a strong selection for cells grown on 5-FOA to lose the URA3 plasmid. Viable ura3 alg2Δ yeast can only grow on 5-FOA if the TRP1-marked plasmid-borne alg2 mutant allele encodes a functional protein that can rescue the chromosomal alg2Δ deletion (25) . To rule out dosage effects of ALG2 overexpression, TRP1-marked expression of alg2 mutant alleles was driven by the endogenous ALG2 promoter in low-copy centromeric plasmids. Each TRP1-marked alg2 allele was also tagged with HA to allow measurement of Alg2 protein levels by Western blot analysis. The results of these experiments demonstrated that both HA-scAlg2 E335A and HA-scAlg2 E343A mutants failed to support the growth of alg2Δ strain on 5-FOA plates (Fig. 4C) , although their protein levels were indistinguishable from the WT HA-Alg2 (Fig. 4D) . These results are in agreement with the experiments described above, and they demonstrate the importance of both E335 and E343 of the EX 7 E domain for Alg2 function in vivo (Fig. 4B) . Interestingly, we also found that Trx-scAlg2 E335A and Trx-scAlg2 H336A produced mainly the Man-(a1,3)-Man 1 Gn 2 isoform intermediate, a result that was confirmed by UPLC (Fig. 4B) and a1,2,3-mannosidase treatment (data not shown). Thus, the second conserved E residue (E343) in the EX 7 E motif of Alg2 is critical for both a1,3-and a1,6-mannosylations, while the first E (E335) and His-336 are partially required for a1,6-mannosylation.
These results are in conflict with those described by Kämpf et al. (12) and therefore raised the question of how they can be reconciled. We considered the possibility that the different activities observed by the same alg2 EX 7 E mutations could be explained by the different strain backgrounds used in these experiments, or by the possibility that Alg2 functions as an oligomer. All our in vivo complementation analyses were performed in a strain containing a complete deletion of ALG2, while Kämpf et al.
used a temperature-sensitive alg2-1 mutant containing a single missense mutation (G377R). If Alg2 were to form homodimers, then coexpression of two different alg2 mutant alleles could result in intraallelic complementation. Although different nonfunctional alg2 alleles encode a defective product when individually expressed, when coexpressed, they may encode polypeptides that physically interact, and this physical interaction could restore activity. Indeed, intraallelic complementation is a genetic hallmark of protein-protein interactions (26, 27) . If this idea were correct, then Alg2 mutant homodimers would be inactive while Alg2 mutant heterodimers would be active.
To test this, we constructed E. coli strains that expressed the Trx-tagged scalg2-1 (G377R) or scalg2 E343A. Membrane fractions were prepared from these E. coli strains and Alg2 activity measured using our MS-based in vitro assay. As shown in Fig. 5 , this experiment demonstrated that neither Alg2 [G377R (M)] nor E343A (M) membrane fractions displayed any mannosyltransferase activity, while 15% of activity was observed in membrane fractions from a mixture of Alg2 [G377R (M)] and E343A (M). These data provided strong evidence that these alg2 alleles display intraallelic complementation and that these genetic interactions can explain the contradictory interpretations concerning the Alg2 EX 7 E motif.
The N-terminal region of scAlg2, including 158 aa, containing both transmembrane domains as well as the short cytosolic tail was reported to be dispensable for Alg2 function because a deletion mutant lacking this domain could complement the temperature sensitivity of the yeast alg2-1 mutant (12). This was surprising because a V68G substitution in the short N-terminus of human Alg2 underlies congenital myasthenic syndrome in humans, and this valine is highly conserved from yeast to human (Fig. 6A) (28) . To test its importance, this V . G mutation was introduced at the corresponding position in scAlg2 (V62G). The recombinant Trx-scAlg2 V62G was purified from E. coli and its activity assayed in vitro. As shown in 10  G19P  G rich  100  0  0  G20P  G rich  100  0  0  G256P  G rich  100  0  0  G257P  G rich  34 
Reactions were performed using purified WT or mutant Trx-scAlg2, GDP-Man, and Man 1 Gn 2 -PPhy. After incubation at 30°C for 10 h, glycans released from phytanyl anchor were subjected to LC-MS analysis.
a Relative percentage of oligosaccharide was calculated using ratio of areas under oligosaccharide peak to total peak. Chromatograms of oligosaccharides that were produced by various mutant proteins are shown in Figs. 4B , 5B, and 6B. Table 2 , this mutation severely affected Alg2 activity, producing ;25% of Man 3 Gn 2 compared to WT Alg2. In addition, the HA-tagged mutant allele (3HA-scAlg2 V62G ) failed to complement the lethality of the alg2Δ LSY2 when grown on 5-FOA (Fig. 6C) , implying that, as in humans, the conserved Val residue is required for yeast Alg2 function.
This conserved V62 lies within a short cytosolic tail of scAlg2 ( Fig. 6A and Supplemental Fig. S1 ). To test if this region is important for Alg2 function, in vitro and in vivo activity assays of mutant Alg2 lacking this N-terminal 65 aa were performed. Recombinant Trx-scAlg2 66-503 purified from E. coli was completely inactive in vitro (Fig. 6B) , and this mutant allele also failed to complement LSY2 when grown on 5-FOA (Fig. 6C) . However, in this case, the Alg2 66-503 protein could not be detected in yeast lysates by Western blot analysis (Fig. 6D) . This experiment suggested that the failure of alg2 66-503 to complement growth on 5-FOA was due to Alg2 protein instability in yeast. These results suggested that the cytosolic N-terminal cytosolic tail is required for correct folding and/or stability of scAlg2.
G-rich motifs are hypothesized to function as flexible loops that are required for the conformational transitions during catalysis of many GTases (29) . We identified three conserved G-rich motifs in scAlg2, located in the N-terminal cytosolic short tail, in the middle of Alg2, and in the Cterminal domain (Fig. 7A and Supplemental Fig. S1 ). Each of these glycines, including G17, G19, G20, G256, G257, G357, and G358, was changed to proline and analyzed in vitro as described above. Each of these Trx-tagged mutant Alg2 proteins was expressed at similar level and purified from E. coli (data not shown). This experiment revealed that mutations in five of these glycines (G19, G20, G256, G357, G358) resulted in complete loss of activity, while two of them (G17, G257) were significantly decreased; scAlg2 G17P converted 10% of substrate to Man 3 Gn 2 LLO, while scAlg2 G257P converted 66% of substrate into the intermediate Man 2 Gn 2 ( Fig. 7B and Table 2 ). Interestingly, scAlg2 G17P and scAlg2 G257P mainly produced a single isoform of intermediate, Man-(a1,3)-Man 1 Gn 2 , a conclusion based on UPLC retention times (Fig. 7B) and a1,2-3-mannosidase treatment (data not shown), indicating that these residues have critical contributions to a1,6-mannosylation. Notably, G17, G19, and G20 are within the N-terminal cytosolic tail of Alg2, further underscoring the importance of this domain for Alg2 function.
DISCUSSION
During the biosynthesis of LLO, Alg2 is responsible for the addition of both the a1,3-and a1,6-Man linkage onto Man 1 Gn2-PDol to generate the trimannosyl core Man 3 Gn 2 -PDol. Although this bifunctionality has been recognized for some time, conflicting reports about the order of these reactions led to a gap in our understanding of these early events in LLO synthesis. In this study, we successfully developed an MS-based quantitative assay for Alg2 activity and applied it to study the enzyme activity of Alg2. This assay allowed us to precisely identify Alg2 reaction intermediates, demonstrating differentially linked Man can be added in either order, as well as amino acids that are required for Alg2 function in vivo and in vitro.
A requirement of E. coli-derived membranes for recombinant Trx-scAlg2 activity has been reported (11) , but the contribution of native bacterial enzymes that copurified in those membrane fractions could not be ruled out (12) . Using proteoliposomes reconstituted from pure phospholipids and recombinant Alg2, we demonstrated the lipids themselves are required for MTase activity (Fig. 2) . Of the 5 lipids we tested, only PC and DGDG efficiently enhanced Alg2 activity ( Fig. 2A) . PC and DGDG are charge net-neutral lipids that have a propensity to form bilayers, and we speculate that these two characteristics are key for enhancing Alg2 activity (Fig. 2B) . Many integral membrane proteins are affected by the lipid that surrounds them because lipid bilayers provide a hydrophobic thickness that matches that of hydrophobic transmembrane domain (30) (31) (32) (33) (34) . On other hand, the charge balance rule proposes that net-neutral lipids like PC and DGDG can balance the charged transmembrane helix ends to dampen the potential of negatively charged residues (30, 33, 35, 36) . scAlg2 has 2 N-terminal transmembrane helices flanked by many charged residues as well as two Figure 5 . In vitro intraallelic complementation of scAlg2 mutants (scalg2-1 G377R and scalg2 E343A). Membrane fractions were prepared from E. coli expressing scalg2-1 G377R and scalg2 E343A as described in Materials and Methods. Reactions were performed using mutant membrane fractions G377R (M), E343A (M), or mixture of these membranes [(G377R (M)] + [E343A (M)] at 30°C for 10 h under standard reaction conditions as described in Materials and Methods. Glycans from oligosaccharide phytanyl products were released and subjected to LC-MS.
hydrophobic C-terminal regions that associate with but do not cross the endoplasmic reticulum (Supplemental Fig.  S1 ) (12) . Net-neutral bilayer lipids PC and DGDG are likely to be necessary to create a bilayer thickness and ionic balance that is optimal for yeast Alg2 topology and function in vitro. In contrast to yeast Alg2, lipids are not required for the in vitro activity of purified human Alg2 (37) . Human Alg2 contains only a single transmembrane domain at its Nterminus (37), so one explanation for the different lipid dependencies of yeast and human Alg2 may stem from their different membrane topologies.
A controversial issue we addressed in this study concerned the role of the conserved C-terminal EX 7 E motif in Alg2 function. This motif is crucial for activity in those GTases so far examined (23, 24, (38) (39) (40) (41) (42) . As expected from its evolutionary conservation, our mutational analyses demonstrated that both glutamic acids (E335 and E343) of the EX 7 E, as well as residues in the intervening 37 positions, are critical for scAlg2 function both in vitro and in vivo (Fig. 4) . A likely explanation for the contradictions in the literature pertaining to the EX 7 E is our observation that certain alg2 mutations display intraallelic complementation in vitro. This was demonstrated by assaying the activity of individual mutant Alg2 proteins or a mixture of these proteins. By this assay, mutant Alg2 hetero-oligomers but not homo-oligomers were active. The mutant alg2 alleles we assayed corresponded to the alg2-1 allele used in previous complementation studies, therefore suggesting that EX 7 E alg2 mutants can complement alg2-1 in vivo through interallelic interactions, as we found in vitro. Our studies also implicate the Nterminal cytosolic tail (from 1 to 66 aa) as a critical determinant of Alg2 stability and thus MTase activity (Fig.  6 ). This result also disagrees with a previous study that reported the dispensability of N-terminal region (from 1 to 158 aa including the both transmembrane domains) for Alg2 in vivo (12) . The effect of interallelic interactions described above may also provide an explanation for this contradiction. These results underscore a cautionary note for in vivo mutational analyses of genes that encode multimeric proteins and the necessity of performing complementation analyses in null mutant backgrounds.
One of the most interesting and unique aspects of Alg2 is its ability to catalyze two different reactions: addition of both the a1,3-and a1,6-linked Man. An important and novel finding in this study is that these 2 reactions can occur independently of one another and in either order, albeit with different kinetics (Fig. 3 ). This finding was made possible by the high sensitivity of ESI-MS, which allowed the separation of mixed Man 2 Gn 2 -PPhy tetrasaccharide intermediates from one another as well as unambiguous confirmation of their structures with mannosidases (Fig. 3C) . Recent studies reported no evidence for the existence of Man-(a1,6)-Man 1 Gn 2 and therefore proposed a model for the Alg2 reaction in which formation of Man-(a1,3)-Man 1 Gn 2 -PPhy is a prerequisite for a1,6-linked Man addition (11, 12) . We propose a different model, in which alternative orders of Man addition are possible. The a1,3-linked Man can be added first, followed by a1,6-linked Man or vice versa (Fig. 8, step 1→2 (Fig. 8, step 4 ). This appears to be a general rule, as yeast and human Alg2 behaved similarly (data not shown). Thus, the major route of Alg2 is the transfer of a1,3-linked Man followed by a1,6-linked Man (Fig. 8, step  1→2) . The seemingly minor Alg2-mediated mannosylation route of glycosylation (Fig. 8, step 3→4 ) warrants attention because it occurs in vivo (8, 13) and, as we show here, in vitro. It is tempting to speculate that this minor route is a means by which cells can regulate flux through the LLO synthesis pathway. Studies by Harada et al. (43) provide indirect evidence for this idea. It has been known for some time that a low-glucose environment can arrest LLO biosynthesis. Harada et al. found that low-glucose-induced arrest of LLO biosynthesis results in substantial reductions of GDP-Man, which in turn leads to release of singly phosphorylated oligosaccharides into the cytosol. The most abundant cytosolic phosphorylated oligosaccharide is Man 2 GlcNAc 2 -P, leading to the hypothesis that the reaction depicted in Fig. 8 , step 2 has a higher K m for GDPMan than step 1 in order to regulate the N-glycosylation state of the cell (43) . In agreement with this idea, our results demonstrate the accumulation of the Man-(a1,3)-Man 1 Gn 2 -PPhy during early stages of the Alg2 reaction, which implies the rate of step 2 is slower than step 1 (Fig. 3A) . This raises the interesting possibility that Alg2 may regulate LLO biosynthesis through the rate-limiting activity of step 2. It will be of interest to test this hypothesis by further biochemical studies of Alg2 that measure the K m for GDP-Man of each step.
An important unanswered question is whether or not the dual Alg2 catalytic activities are distinct or share the same active site. For several reasons, we favor the idea that addition of both a1,3-and a1,6-linked Man are catalyzed via the same catalytic site. First, most bifunctional GTases are large (about 100 kDa) and contain two distinct, recognizable catalytic domains (44) (45) (46) (47) . In contrast, Alg2 is a small protein (503 aa) whose predicted catalytic domain is a GT-B fold. This fold consists of 2 Rossmann-like domains that face each other, with the catalytic site residing in the cleft between them (48). In addition, for bifunctional GTases with two separate domains, site-directed mutagenesis of residues in each domain specifically affect the corresponding sugar addition (44) (45) (46) . Mutation of numerous Alg2 residues throughout its length has failed to identify any that specifically affect a1,3-linked Man additions, implying that both of a1,3-and a1,6-linked Man additions are catalyzed via the same catalytic site.
If Alg2 has a single catalytic site, how can it carry out catalysis of two different linkages? Structural analyses of several GTase implicate one or two flexible G-rich loops at the substrate binding site that undergo a marked conformational transition upon donor binding (29, 34, (49) (50) (51) . We hypothesize that Alg2 catalyzes Man 1 Gn 2 -PDol to Man 3 Gn 2 -PDol through sequential conformation transitions that involve G-rich flexible loops at Gly17 and Gly257. These residues are highly conserved and critical for a1,6-mannosylation of Man-(a1,3)-Man 1 Gn 2 -PDol (Fig. 8, step 2; Fig. 7B ). One hypothesis is when Alg2 transfers the a1,3-linked Man to Man 1 Gn 2 -PDol (Fig. 8,  step 1) , a conformational transition mediated by a G-rich loop alters the specificity required for subsequent transfer of a1,6-linked Man to Man-(a1,3)-Man 1 Gn 2 -PDol. Testing this hypothesis will require structural studies to define the conformational changes in Alg2 that are triggered by its various substrate interactions during a1,3-and a1,6-linked Man addition. Several mutations we identified, including scAlg2 H336A (Fig. 4 ) and scAlg2 G257P (Fig. 8) , produce only Man-(a1,3)-Man 1 Gn2-PPhy. These mutants, along with the in vitro system we described, suggest the feasibility of future cryoelectron microscopy studies using these mutants as an approach to capture these transient intermediate complexes.
